Monte Rosa Therapeutics, Inc. ($GLUE)
Filing Information
| Accession Number | 0001193125-26-292767 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 1, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
16,221
Total Value
$204,979.37
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Jun 30, 2026 | Exercise/Conversion | 5,407 | $13.41 | $72,507.87 | 66,019 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jun 30, 2026 | Sale | 5,407 | $24.50 | $132,471.50 | 60,612 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (Right to Buy) | Derivative | Jun 30, 2026 | Exercise/Conversion | 5,407 | $0.00 | $0.00 | 81,093 | Direct | โ | View Details |